Gemini Bioproducts LLC, a supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, has launched the Moxi V for precision cell analysis.   The Moxi V utilizes the Coulter Principle to precisely measure cell volumetric sizes, enabling researchers to easily track detailed size profiles in their cell samples. This exact cell sizing capability of the Moxi V is an essential requirement for the monitoring of T-Cell activation curves for CAR-T cell research in immunot...